# Outcomes in Asymptomatic Patients Undergoing Coronary Revascularization Before Liver Transplantation

**Authors:** Goyal Umadat, Jennifer Lee, Jordan C. Ray, Ryan M. Chadha, Yaohua Ma, Hanna J. Sledge, Surakit Pungpapong, Leslie E. Janik, Dilip Pillai, Abdallah El Sabbagh, Peter Pollak, Shahyar M. Gharacholou

PMC · DOI: 10.3390/jcm14197067 · 2025-10-07

## TL;DR

This study found that pre-transplant coronary intervention in asymptomatic liver transplant candidates with severe heart disease did not improve outcomes after the transplant.

## Contribution

The study provides new evidence that PCI does not reduce major adverse cardiovascular events in asymptomatic liver transplant candidates with severe CAD.

## Key findings

- PCI did not reduce post-transplant MACE compared to medical management.
- Prior MI and pre-transplant dialysis were independent predictors of MACE.
- Major bleeding occurred in 7% of patients undergoing PCI.

## Abstract

Background: Coronary artery disease (CAD) is common among liver transplantation (LT) candidates, yet whether pre-transplant percutaneous coronary intervention (PCI) improves post-LT outcomes remains uncertain. Methods: We conducted a single-center, Institutional Review Board-approved cohort study of adults undergoing LT from 2005 to 2025. Asymptomatic candidates with significant stenosis on invasive angiography were included; prior coronary artery bypass grafting was excluded. The primary endpoint was major adverse cardiovascular events (MACE: myocardial infarction [MI], stroke/transient ischemic attack, new systolic dysfunction, post-LT coronary revascularization, or all-cause death). Results: Among 111 patients (median age 65 years; 84% male), 66 (59%) underwent PCI and 45 (41%) were managed medically. Over a median 32 months of follow-up, 61 patients (55%) experienced MACE. Composite MACE did not differ between PCI and non-PCI groups (52% vs. 60%, p = 0.40; log-rank p = 0.59). Fine–Gray modeling showed no association of PCI with MACE; independent predictors were prior MI (HR 1.81, 95% CI 1.01–3.24) and pre-transplant dialysis (HR 2.13, 95% CI 1.07–4.24). Major bleeding occurred in 7%. Matched and era-stratified analyses were concordant. Conclusions: In asymptomatic LT candidates with angiographically severe CAD, pre-LT PCI was not associated with a lower incidence of post-LT MACE.

## Linked entities

- **Diseases:** coronary artery disease (MONDO:0005010), myocardial infarction (MONDO:0005068), stroke (MONDO:0005098), transient ischemic attack (MONDO:0005264)

## Full-text entities

- **Diseases:** death (MESH:D003643), transient ischemic attack (MESH:D002546), stroke (MESH:D020521), CAD (MESH:D003324), systolic dysfunction (MESH:D006331), stenosis (MESH:D003251), bleeding (MESH:D006470), myocardial infarction (MESH:D009203)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12525977/full.md

---
Source: https://tomesphere.com/paper/PMC12525977